In the latest Crunchbase Megadeals Board, electric‑vehicle maker Slate Auto secured $650 million in Series C funding, topping a list that spots biotech, autonomous transport and fintech on the rise.

The round, led by TWG Global, follows the company's plan to ship its first low‑cost pickup trucks later this year. Other headline deals include $300 million for Boston‑based Beeline Medicines and $170 million for San Francisco’s Glydways, moving autonomous pods closer to market.

Factory, a 3‑year‑old AI software firm, raised $150 million and reached a $1.5 billion valuation, while Terremoto Biosciences added $108 million to its oncology pipeline. These investments signal a shift toward high‑capability tech and life‑science startups that can scale quickly.

The cluster of deals underscores investor appetite for scalable, tech‑driven solutions across transportation, healthcare and software, positioning these firms for significant growth and potential market disruption.